Total Value
$700.44B
Holdings Count
4
Period of Report
Sep 30, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 02043Q107 | $634.89B | 1,392,303 |
| Intellia Therapeutics, Inc. | 45826J105 | $63.95B | 3,702,995 |
| Adverum Biotechnologies, Inc. | 00773U207 | $819.5M | 180,909 |
| Adicet Bio, Inc. | 007002108 | $784.4M | 968,183 |